Nova Minerals Corp filed a Form 8-K with the SEC on November 10, 2026, disclosing under Item 7.01 (Regulation FD) that it issued a press release confirming 216,000 tonnes per annum processing capacity at its Alaska project.
Brightstar Lottery PLC filed a Form 6-K on November 10, 2026, reporting its third quarter results for the period ended September 30, 2026, and announcing a quarterly cash dividend of $0.23 per ordinary share.
Brightstar Lottery PLC filed its third-quarter 2026 earnings release on November 10, 2026, reporting revenue of $607 million and Adjusted EBITDA of $289 million for the quarter ended September 30, 2026, while updating its full-year revenue and Adjusted EBITDA outlook.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 19,605,453 shares of Automatic Data Processing Inc. common stock, representing 4.9% of the class, as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,563,226 shares of Avalo Therapeutics Inc. common stock as of September 30, 2026.
WhiteFiber, Inc. filed a Form 8-K on November 10, 2026, disclosing that two of its indirect wholly owned subsidiaries entered into a $300.0 million Term Loan Credit Agreement on November 9, 2026, with Morgan Stanley Senior Funding, Inc. as administrative agent, collateral agent, lead …
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 12,294,412 shares of BioCryst Pharmaceuticals Inc common stock as of September 30, 2026.
Taiwan Semiconductor Manufacturing Co Ltd EVP and Co-COO Mii Yuh-Jier filed a Form 4 on November 10, 2026, disclosing a purchase of 73 Common Shares on November 6, 2026, through the company's Employee Stock Purchase Plan.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,595,632 shares of Avery Dennison Corp common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 7,570,589 shares of Biogen Inc. common stock, representing 5.1% of the class, as of September 30, 2026.